Medical Supplies Market 2018-2023: Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), Medtronic plc (Ireland)

[227 Pages Report] The Global Medical Supplies Market is projected to grow from USD 133.5 billion by 2025 from USD 132.6 billion in 2020, at a CAGR of 4.6%.

Market Size Estimation;

Both top-down and bottom-up approaches were used to estimate and validate the total size of the medical supplies market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

• The key players in the industry and market have been identified through extensive secondary research.
• The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
• All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation;

After arriving at the overall medical supplies market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the medical supplies industry.

Browse 126 market data Tables and 45 Figures spread through 227 Pages and in-depth TOC – Request Research Sample Pages: 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=64344238

Market Segmentation in Depth:

By type, the medical supplies market is segmented into diagnostic supplies, infusion & injectable supplies, intubation & ventilation supplies, disinfectants, personal protective equipment, sterilization consumables, wound care consumables, dialysis consumables, radiology consumables, catheters, sleep apnea consumables, and other medical supplies. The intubation & ventilation supplies segment is expected to grow at the highest growth rate during the forecast period. The growth of this segment is driven mainly by the rising prevalence of respiratory diseases such as asthma and COPD across the globe.

The applications market is categorized into urology, wound care, radiology, respiratory, infection control, cardiology, IVD, and other applications. The other applications segment held the largest market share in 2019, due to factors such as the increasing number of surgical procedures, rising prevalence of dental diseases, and the increasing focus on adhering to proper waste disposal methods.

Download PDF Brochure: 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64344238

Geographical Analysis in Detailed:

The global medical supplies market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest market share, followed by Europe. The increasing incidence of COVID-19 in the US and the implementation of various supportive initiatives by the Canadian Government are the major factors driving the growth of the medical supplies market in North America.

Major Key Players:

The prominent players operating in the global medical supplies market include Medtronic (Ireland), Cardinal Health, Inc. (US), BD (US), Johnson & Johnson (US), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Thermo Fisher Scientific, Inc. (US), Baxter International, Inc. (US), Avanos Medical, Inc. (US), 3M (US), Smith & Nephew (Ireland), ConvaTec Group Plc. (UK), Abbott (US), Cook Medical (US), Merit Medical Systems (US), Stryker (US), Terumo Corporation (Japan), Teleflex Incorporated (US), Fresenius Medical Care AG & Co. KGaA (Germany), and Coloplast Group (Denmark).

Asia Critical Care Equipment Market Trends and Industry Analysis Report 2019

The Critical Care Equipment Market is expected to reach $2.61 billion, at a CAGR of 8.0% during the forecast period.

Continuous technological advancements in critical care devices, increasing government support, growing private sector investments in the healthcare industry, and increasing patient population base are key factors fuelling the growth of the north africa critical care equipment market in the emerging nations. High replacement rate of critical care devices, growing medical tourism in Asia, and development of multi parameter monitors are some other prime factors offering growth opportunities for players in the critical care devices market. However, high cost of these devices is restraining the growth of this market.

Browse 19 market data Tables and 49 Figures spread through 159 Pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=261496124

Research Methodology Adopted:

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the north africa critical care equipment market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each product in emerging nations.

Market Segmentation in Depth:

On the basis of product, the critical care devices market is divided into three major segments, namely, patient monitors, ventilators, and infusion pumps. The patient monitors segment is estimated to hold the largest share of the market in emerging nations. Increasing patient population base, development of new patient monitors with wireless and sensor technology, and increasing private sector investments are driving the growth of this market segment.

The ventilators market segment is further categorized on the basis of products into adult ventilators and neonatal/infant ventilators. Increasing geriatric population, rising number of ICU patients in India, growing use of home care ventilation devices, and increasing prevalence of respiratory devices are key factors driving the market for adult ventilators in the emerging nations. Whereas, increasing incidence of pre-term births in emerging nations is a key factor driving the adoption of neonatal ventilators in these regions.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=261496124

Asia is estimated to hold the largest share of the north africa critical care devices market, followed by Middle East and North Africa. The Indian critical care equipment market is expected to grow at the highest CAGR. Presence of a large geriatric population, increasing prevalence of chronic and respiratory diseases, improving healthcare infrastructure in rural areas, and increasing number of super-specialty hospitals in India are propelling the growth of the Indian critical care devices market.

Koninklijke Philips N.V. (Netherlands), General Electric Company (U.S.), Medtronic plc (U.S.), Drägerwerk AG & Co. KGaA (Germany), Skanray Technologies Pvt. Ltd (India), Maquet Holding B.V. & Co. KG. (Germany), B. Braun Melsungen AG (Germany), and Fresenius Kabi (Germany) are some of the key players operating in the Asia and North Africa Critical Care Equipment Market

Sugar-Based Excipients Market 2020, Global Industry Analysis,Share, Trends, Status and Future Forecast

According to the new market research report “Sugar-Based Excipients Market by Product (Actual Sugars, Sugar Alcohols, Artificial Sweeteners), Type (Powder/Granule, Crystal, Syrup), Functionality (Filler & Diluent, Tonicity Agents), Formulation (Oral, Topical, Parenteral) – Global Forecast” published by MarketsandMarkets™.

The Global Sugar-Based Excipients Market is estimated to grow at a CAGR of 4.3%, to reach USD 1,060.6 Million.

Market Growth Drivers:

• Increasing Use of Co-Processed Excipients
• Patent Cliffs Driving the Demand for Sugar Excipients in the Generics Market
• Increasing Development of Orally Disintegrating Tablets (ODTS)
• Shifting Focus of Pharmaceutical Manufacturing to Emerging Countries

Browse 125 market data tables and 34 figures spread through 187 pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=242342136

Market Segmentation in Detailed:

Based on product, the market is segmented into actual sugars, sugar alcohols, and artificial sweeteners.

Based on type, the market is segmented into powders/granules, direct compression sugars, crystals, and syrups. Similarly, on the basis of functionality, the market is segmented into fillers & diluents, flavoring agents, tonicity agents, and other functionalities.

Based on formulation, this market is segmented into oral formulations, parenteral formulations, topical formulations, and other formulations.

Based on functionality, fillers & diluents segment accounted for the largest share in this market. The large share of this segment is primarily attributed to huge utilization of fillers and diluents in the development and production of oral dosage forms such as tablets, capsules, and syrups.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=242342136

Geographical Regions Mapped in Report:

Europe is the largest regional segment for the global sugar excipients market. The large share of this regional segment can be attributed to increasing investments in drug development, increasing production of generic drugs, and favorable government initiatives in the region. The market in the Asia-Pacific region is expected to register the highest CAGR owing to the significant growth in the regional healthcare market as well as the pharmaceutical industry, growing scientific base and capability, and favorable government policies, and low-cost manufacturing advantage in this region.

The Maior Key Players Mapped in Research Report:

Roquette Group (France), DFE Pharma (Germany), BASF SE (Germany), and Ashland Inc. (U.S.), held the major share of the sugar excipients market, and are expected to dominate the market during the forecast period. Other major players in this market are Associated British Foods Plc (U.K.), Cargill, Inc. (U.S.), Colorcon, Inc. (U.S.), FMC Corporation (U.S.), MEGGLE AG (Germany), and The Lubrizol Corporation (U.S.).

Global Molecular Cytogenetics Market 2020: Developments, Challenges, and Forecast Report

[147 Pages Report] The Molecular Cytogenetics Market is projected to reach $2.52 Billion, at a CAGR of 10.1%

The report “Molecular Cytogenetics Market by Product (Kit, Reagent, Probe, Consumable, Software, Service), Technique (In-Situ, FISH, Comparative Genomic Hybridization), Application (Cancer, Genetic), End User (Research Labs, Institutes) – Forecast”, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, and strategies impacting the market along with the estimates and forecasts of the revenue and market share analysis.

Targeted therapies differ from standard chemotherapy in several ways. These therapies act on specific molecular targets associated with cancer, whereas most standard chemotherapies act on all rapidly dividing normal and cancerous cells. In solid tumors, significantly high levels of chromosome abnormalities have been detected, but distinction between critical and irrelevant events has been a major challenge. The emergence of molecular-based cytogenetic techniques such as fluorescence in situ hybridization is particularly useful for solid malignancies, and the spectrum of their application is rapidly expanding to improve efficiency and sensitivity in cancer prevention, diagnosis, prognosis, and therapy selection, alone or in combination with other diagnostic methods. The increasing use for molecular cytogenetics in clinical oncology will drive the growth of the global market.

Browse 78 market data tables and 47 figures spread through 147 pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=148469224

Market Segmentation in Detailed:

On the basis of techniques, the molecular cytogenetics market is segmented into comparative genomic hybridization, fluorescence in situ hybridization, in situ hybridization, and other techniques.

Based on applications, the market is segmented into genetic disorders, cancer, personalized medicine, and other applications. The genetic disorders segment is expected to account for the largest share of the global market.

Based on end users, the molecular cytogenetics market is segmented into clinical and research laboratories, academic research institutes, pharmaceutical and biotechnology companies, and others. The clinical and research laboratories segment is expected to account for the largest share of the global market. Rise in healthcare expenditure has resulted in the increasing diagnosis of genetic disorder and cancer resulting in increasing use of cytogenetic kits and reagents in the above mentioned end users.

Major Market Developments

• In January 2014, Roche acquired Genia Technologies, Inc. (U.S.). This acquisition strengthened Roche’s Next Generation Sequencing pipeline.
• In February 2015, Roche acquired Signature Diagnostics AG (Germany).
• In January 2016, Thermo Fisher Scientific, Inc. acquired Affymetrix (U.S.). This acquisition strengthened Thermo Fisher Scientific’s leadership into bioscience business and create new market opportunities in genetic analysis.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=148469224

Based on regions, the global molecular cytogenetics market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as increase in the aging population and increasing prevalence of cancer and genetic disorders in the region.

Key players in the molecular cytogenetics market include F. Hoffmann-La Roche Ltd. (Switzerland) Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies (U.S.), PerkinElmer, Inc. (U.S.), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Gene Technology (U.K.), and Applied Spectral Imaging (U.S.).

High-Resolution Melting Analysis Market expected to grow at a 3.1% CAGR

The report "High Resolution-Melting Analysis Market by Product (Supermix Reagent, RT PCR Instrument, Software), Application (SNP Genotyping, Mutation Discovery, Epigenetics), Enduser (Research Laboratories, Hospital, Diagnostic Center) - Global Forecast", report provides a detailed overview of the major drivers, restraints, and threat impacting the high-resolution melting analysis market along with the estimates and forecasts of the revenue and market share analysis.

The Global High-Resolution Melting Analysis Market is expected to reach $302.1 Million, at a CAGR of 3.1% during the forecast period

Rising prevalence of infectious diseases and genetic disorders; increasing public-private investments, funds, and grants for research on genetic analysis technologies; and advantages of HRM over other genotyping technologies are the major factors driving market growth.

Download PDF (Please provide your specific interest in this report so as to help you better): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=216456020

On the basis of product & service:

The Market is segmented into instruments, reagents & consumables, and software & services. The reagents and consumables segment dominated the market in 2016; and is expected to continue to dominate the market during the forecast period. The segment is also expected to grow at the highest CAGR during the forecast period.

On the basis of application:

The High-Resolution Melting Analysis Market is broadly classified into SNP genotyping, mutation scanning, species identification, pathogen identification, epigenetics, and other applications. In 2016, the SNP genotyping segment accounted for the largest share of the Market. This can be attributed to the wide range of applications of SNP genotyping in the diagnosis of genetic and autoimmune diseases, study of the variations in drug responses, drug discovery & development, and the identification of genetic variations in plant or animal genomes.

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=216456020

On the basis of region:

the market is segmented into North America, Europe, Asia-Pacific, and RoW. In 2016, North America (comprising the U.S. and Canada) accounted for the largest share of the global market, followed by Europe. The rising prevalence of infectious diseases, genetic disorders, & other chronic diseases, and the large number of genotyping-based research and development projects are key growth drivers for the HRM market in North America.

Prominent Key Players in High-Resolution Melting Analysis Market:

Thermo Fisher Scientific Inc. (U.S.), F. Hofmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories (U.S.), and QIAGEN N.V. (Netherlands), Agilent Technologies Inc. (U.S.), bioMérieux S.A. (France), Illumina, Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), Novacyt (France), Azura Genomics (U.S.), Canon Biomedical (U.S.), and PREMIER Biosoft (U.S.).

Viral Clearance Market 2018 Dynamics Set For Rapid Growth and Trend by 2023

According to the new market research report “Viral Clearance Market by Application (Recombinant Proteins, Blood, Vaccines), End User (Pharmaceutical & Biotechnology Companies, CROs), Method (Viral Removal (Chromatography, Nanofiltration), Viral Inactivation (Low pH)) - Global Forecast”, published by MarketsandMarkets™.

Revenue Growth of the Market:

The Global Viral Clearance Market is expected to reach $724.5 million by 2023 from USD 271.2 million in 2018, at a CAGR of 21.7% during the forecast period.

Market Segmentation:-

On the basis of application, the global market is segmented into four categories recombinant proteins, blood and blood products, vaccines, and other applications. In 2018, the recombinant proteins segment is expected to account for the largest share of the viral clearance market owing to the high potential of recombinant proteins to treat various diseases, fewer side effects, and shorter development time as compared to small molecules.

On the basis of the method, the viral clearance market is segmented into viral removal and viral inactivation. In 2018, the viral removal segment is expected to account for the largest share of the global market due to the growth in the biopharmaceutical R&D activities; the high acceptance of this method; and the accuracy, speed, and flexibility provided by the method in life sciences research

Download PDF (Please provide your specific interest in this report so as to help you better.): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=62681197

Market Growth Drivers:

• Growth in the Pharmaceutical and Biotechnology Industries
• Increasing Number of Drug Launches
• High Incidence and Large Economic Burden of Chronic Diseases
• Possibility of Cell Culture Contamination
• Advancements in Nanofiltration Technology

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=62681197

Geographical Analysis:

The North American region is expected to account for the largest share of the market in 2018.

However, Asia Pacific is expected to witness the highest growth during the forecast period, owing to increase in generics development and manufacturing, surge in funding for medical research and the presence of a large number of CROs to provide preclinical and clinical research services in China, government initiatives to boost the use of generic drugs, increasing aging population in Japan, rise in pharmaceutical R&D expenditures in India, and the growing pharmaceutical manufacturing in Singapore and Malaysia.

Major Key Players In Global Viral Clearance Market:

Wuxi Biologics (Cayman) (China), Merck KGaA (Germany), Charles River Laboratories International Inc. (US), and Texcell Inc. (France), Kedrion (Italy), Vironova Biosafety (Sweden), Clean Cells (France), BSL BIOSERVICE Scientific Laboratories Munich GmbH (Germany), and ViruSure GmbH (Austria).

Leukapheresis Market Size 2018, Global Industry Analysis,Share, Trends, Status and Future Forecast 2023

The major factors driving the growth of the Leukapheresis Market include the rising incidence and prevalence of leukemia, growing demand for leukopaks, and the increasing number of blood donations. Leukopaks are enriched leukapheresis products that contain higher concentrations of leukocytes.

The Leukapheresis Products Market is expected to reach USD 27.7 million, at a CAGR of 7.4%

The Leukopaks Market is expected to reach USD 445.6 million, at a CAGR of 46.4% during the forecast period.

Leukapheresis Market Major Drivers;

Increasing incidence and prevalence of leukemia;

Globally, the incidence of leukemia has risen significantly. According to the NIH National Cancer Institute in 2015, 405,815 people were suffering from leukemia in the US. According to NIH estimates, the number of new cases of leukemia has increased on an average rate of 0.3% each year over the last 10 years (from 2006 to 2015). The NIH also estimates that the number of new cases may reach 60,300 in 2018. According to the Leukemia & Lymphoma Society, from 2010 to 2014, leukemia was the sixth-most-common cause of cancer deaths globally.

Browse 134 market data Tables and 49 Figures spread through 194 Pages and in-depth TOC  – Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20283148

Leukapheresis Market Segmentation:

By product, the apheresis devices segment is expected to account for the largest share of the leukapheresis devices market in 2018

On the basis of type, the leukapheresis devices market is segmented into apheresis devices, leukapheresis columns & cell separators, and leukoreduction filters. In 2017, the apheresis devices segment accounted for the largest share of the leukapheresis devices market. The large share of this segment is attributed to the widespread adoption of apheresis devices for performing therapeutic leukapheresis procedures for the treatment of leukemia and development of leukopaks for clinical and preclinical research.

By product, the mobilized PB leukopaks segment is expected to account for the largest share of the leukopaks market in 2018

On the basis of type, the leuopaks market is segmented into mobilized PB leukopaks, non-mobilized PB leukopaks, diseased leukopaks, and isolated PBMCs. The mobilized PB leukopaks segment is expected to account for the largest share of the global leukopaks market in 2018. The dominant share of this segment is attributed to the increasing demand for low-granulocyte and low-hematocrit contamination, high cell viability, and an increase in CD34+ cell frequencies for the development of immunotherapies.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=20283148

Asia Pacific is expected to account for the largest share of the leukapheresis market in 2018, followed by North America. The increase in regenerative medicine research in the region, growth in the number of clinical trials for CAR-T therapy, and the presence of leading pharma and biotech companies focusing on cell therapy research are factors are driving the growth of this regional segment.

The prominent players in the global leukapheresis products market are Asahi Kasei Medical (Japan), Fresenius (Germany), Haemonetics Corporation (US), Terumo BCT (US), STEMCELL Technologies (Canada), and Macopharma (France).

Some prominent players in the leukopaks market are HemaCare (US), AllCells (US), StemExpress (US), PPA Research Group (US), Key Biologics (US), Caltag Medsystem (UK), ZenBio (US), Precision for Medicine (US), and BioIVT (US).

Global Ureteroscopy Market 2019 Industry Analysis, Size, Share, Growth, Trends and Forecast

The high incidence of urolithiasis across the globe is a major factor driving the growth of this market. The rapidly increasing geriatric population, technological advancements in devices, and improving hospital infrastructures are the other major factors that are expected to support the growth of the flexible ureteroscopy market in the coming years.

The Research Report on Ureteroscopy Market provides a detailed overview of the major Factors such as the growing incidence of urolithiasis and technological advancements such as single-use ureteroscopes in flexible ureteroscopy are driving the growth of this market.

[101 Pages Report] The global flexible & semi-rigid ureteroscopy market is expected to reach USD 1,054.1 million by 2023 from USD 768.0 million in 2017, at a CAGR of 5.4%.

The Objectives of this Study are as follows:

To define, describe, and forecast the flexible ureteroscopy market by product type, application, end user, and region

To forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)

To identify the micro-markets with respect to drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the market

To analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market

Download PDF (Semi-rigid Ureteroscopy Market):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=253934795

Research Methodology:

Top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation—by type, application, end user, and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.

This research report segments this Ureteroscopy Market based on product type, application, end user, and region

Ureteroscopy Market Segmentation in Detailed:

By product type, the flexible ureteroscopy market is categorized into flexible and semi-rigid ureteroscopes. The flexible ureteroscopes segment is expected to account for the largest share of the global flexible & semi-rigid ureteroscopy market in 2018. Also, technological advancements are allowing hospitals to switch from rigid/semi-rigid ureteroscopes to flexible and fully digital ureteroscopes for improving the accuracy and effectiveness of treatment procedures as well as reducing their overall cost. The flexible ureteroscopes market is further segmented into fiber optic and digital ureteroscopes

Based on application, the flexible & semi-rigid ureteroscopy market is segmented into urolithiasis, urinary stricture, and kidney cancer. Urolithiasis is the largest application segment. Market growth can primarily be attributed to the increasing incidence of kidney stones and the widespread adoption of ureteroscopes in diagnostics.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=253934795

Market Based on Region;

On the basis of region, the flexible & semi-rigid ureteroscopy market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2018, North America is expected to command the largest share of the ureteroscopy market.

The large share of this market segment can be attributed to the high prevalence of kidney stones in this region and a large number of surgeries performed each year. However, the high cost of ureteroscopy procedures is expected to restrain the growth of this market during the forecast period.

Some of the major players operating in this market are Olympus (Japan), Stryker (US), Boston Scientific (US), KARL STORZ (Switzerland), Richard Wolf (Germany), ELMED Medical Systems (Turkey), Rocamed (France), Maxer Endoscopy (Germany), ProSurg (US), and Vimex Endoscopy (Poland).